References
Holm KJ, Spencer CM. Bupropion: a review of its use in the management of smoking cessation. Drugs. 2000;59:1007–24.
Van Wyck Fleet J, Manberg PJ, Miller LL, et al. Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry. 1983;44:191–6.
Uptodate.com. http://www.uptodate.com/contents/bupropion-drug-information. Accessed 26 May 2013.
Laizure SC, DeVane CL, Stewart JT, et al. Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin Pharmacol Ther. 1985;38:586–9.
Turpeinen M, Koivuviita N, Tolonen A, et al. Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites. Br J Clin Pharmacol. 2007;64:165–73.
Acknowledgements
None.
Conflict of interest
The authors declare that there are no actual or potential conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kinalp, C., Kurultak, I., Ceri, M. et al. Serum creatinine elevation caused by bupropion. Wien Klin Wochenschr 126, 138–139 (2014). https://doi.org/10.1007/s00508-013-0466-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-013-0466-4